Loading...
Loading...
Cara Therapeutics Inc. CARA was a big mover last session, as the company saw its shares surge over 19% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 28.28% in the past one-month time frame.
In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged. However, Friday's price action is encouraging, so make sure to keep a close watch on this firm in the near future.
Cara Therapeutics Inc. currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other players in the healthcare industry include Illumina Inc. ILMN, Gilead Sciences Inc. GILD and ANI Pharmaceuticals, Inc. ANIP all carrying a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free reportCARA THERAPEUTC CARA: Free Stock Analysis Report
GILEAD SCIENCES GILD: Free Stock Analysis Report
ILLUMINA INC ILMN: Free Stock Analysis Report
ANI PHARMACEUT ANIP: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: MoversTrading Ideas
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in